Abstract
A polymerase chain reaction (PCR) test for CMV DNA was evaluated for clinical usefulness. Leukocytes and serum were sampled from 36 patients who had recently undergone organ transplantation. Clinical symptoms, virus culture, and IgG and IgM antibodies were used to identify, in retrospect, patients with CMV disease certified beyond all doubt, with probable disease, with asymptomatic infection, or without infection. PCR tests for CMV DNA in leukocytes (BC-PCR) and serum (SE-PCR) were then evaluated. BC-PCR was positive in all patients with certified CMV disease but also in 31% of the samples from patients without infection. SE-PCR was positive in 11/13 patients with certified disease and was concordant with CMV culture in 192/231 tests. Of the 39 discordant cases, 27 had a positive SE-PCR with a negative culture. The effect of ganciclovir treatment could not be predicted by any test. In conclusion, a negative BC-PCR is strong evidence against CMV disease and a positive SE-PCR strongly suggests CMV disease, but the opposite results are of little clinical help.
Similar content being viewed by others
References
Berg AP van den, Bij W van der, Son WJ van, Anema J, Giessen M van der, Schirm J, Tegzess AM, The TH (1989) Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation — a report of 130 consecutive patients. Transplantation 48: 991–995
Boland GJ, Weger RA de, Tilanus MG, Ververs C, Bosboom-Karlsbeek K, Gast GC de (1992) Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol 30: 1763–1767
Delgado R, Lumbreras C, Alba C, Pedraza MA, Otero JR, Gomez R, Moreno E, Noriega AR, Paya CV (1992) Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol 30: 1876–1878
Dorp WT van, Vlieger A, Jiwa NM, Es LA van, Ploeg M van der, Saase JLCM van, Woude FJ van der (1992) The polymerase chain reaction, a sensitive and rapid technique for detecting cytomegalovirus infection after renal transplantation. Transplantation 54: 661–664
Dunn DL, Mayoral JL, Gillingham KJ, Loeffler CM, Brayman KL, Kramer MA, Erice A, Balfour HH, Fletcher CV, Bolman RM, Matas AJ, Payne WD, Sutherland DER, Najarian JS (1991) Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation 51: 98–106
Fischer L, Rautenberg P, Bienengräber H, Leimenstoll G (1993) Antigenemia, immunoblotting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant patients. Transpl Int 6: 201–205
Gerdes JC, Spees EK, Fitting K, Hiraki JD, Sheehan MA, Duda D, Jarvi T, Roehl C, Robertson AD (1993) Prospective study utilizing a quantitative polymerase chain reaction for detection of cytomegalovirus DNA in the blood of renal transplant patients. Transplant Proc 25: 1411–1413
Grundy JE, Griffiths PD (1989) A cyclovir to prevent cytomegalovirus infection in renal-graft recipients. Lancet II: 1268
Koskinen PK, Nieminen MS, Mattila SP, Häyry PJ, Lautenschlager IT (1993) The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation 55: 547–551
Krishna RV, Meurman OH, Ziegler Y, Krech UH (1980) Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus. J Clin Microbiol 12: 46–51
Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339: 237–238
Landgren M, Kyllerman M, Bergström T, Dotevall L, Ljungström L, Ricksten A (1994) Diagnosis of Epstein-Barr virus-induced central nervous system infections by DNA amplification from cerebrospinal fluid. Ann Neurol (in press)
Lautenschlager I, Höckerstedt K, Salmela K (1994) Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant patients. Transplant Proc (in press)
Lee WT, Antoszewska H, Powell KF, Collins J, Doak PB, Williams LC, Munn S, Verran D, Croxson MC (1992) Polymerase chain reaction in detection of CMV DNA in renal allograft recipients. Aust N Z J Med 22: 249–255
Saiki R, Gelfand DH, Stoffel S, Scharf, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491
Studahl M, Ricksten A, Sandberg T, Bergström T, Elowson S (1992) Cytomegalovirus encephalitis in four immunocompetent patients. Lancet 340: 1045–1046
The TH, Ploeg M van der, Berg AP van den, Vlieger AM, Giessen M van der, Son WJ van (1992) Direct detection of cytomegalovirus in peripheral blood leukocytes — a review of the antigenemia assay and the polymerase chain reaction. Transplantation 54: 193–198
The TH, Berg AP van den, Son WJ van, Klompmaker IJ, Harmsen MC, Giessen M van der, Slooff MJH (1993) Monitoring for cytomegalovirus after organ transplantation: a clinical perspective. Transplant Proc 5 [Suppl 4]: 5–9
Author information
Authors and Affiliations
About this article
Cite this article
Nyberg, G., Bergström, T., Blohmé, I. et al. Clinical evaluation in organ transplant patients of a polymerase chain reaction test for CMV DNA applied on white blood cells and serum. Transpl Int 7, 428–433 (1994). https://doi.org/10.1007/BF00346037
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00346037